ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

Cancer Letter Office Moves To Capitol Hill; No Issues Published Next Two Weeks

September 1, 1989

Kimes Calls Headline On DRG ‘Exaggerated Negativity’ In Letter

April 5, 1991

Fadlo Khuri Named Editor-in-Chief Of ACS Journal Cancer

August 12, 2011

HHS Approves States Plans For Breast, Cervical Cancer Treatment For Uninsured.

April 6, 2001

In Brief: Reginald Ho Assumes ACS Presidency; Board Calls On NCI To Fully Fund ASSIST Program

November 13, 1992

Senate Raises Funding For Cervical, Ovarian, Prostate Cancer

September 18, 1992